サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1574934

結核検査市場：検査タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Tuberculosis Testing Market, By Test Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 284 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.73円
結核検査市場：検査タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

2023年の結核検査市場規模は22億9,032万米ドルで、2024年から2032年にかけてCAGR 5.99％で拡大

結核検査市場-市場力学

薬剤耐性結核菌の増加が検査需要を牽引

薬剤耐性結核菌の増加は、結核検査市場の重要な促進要因です。このような耐性株が一般的になるにつれ、効果的な治療にはタイムリーで正確な検査が不可欠となります。米国疾病予防管理センター（CDC）によると、米国で新たに診断された結核患者の約3％が薬剤耐性です。この統計は、耐性株を特定し、効果的に管理するための高度な検査ソリューションの緊急の必要性を浮き彫りにしています。ヘルスケア提供者は、適切な治療を確実に行い、結核の蔓延を抑制するために、信頼性の高い診断ツールを必要としています。結核に対する認識が高まるにつれ、革新的な検査方法に対する需要は高まり続け、市場の成長を支えると思われます。

結核検査市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約5.99%のCAGRで毎年成長すると推定されます。

検査タイプ別では、分子診断薬が2023年に最大の市場シェアを示すと予測されています。

エンドユーザー別では、病理検査室が2023年の主要タイプでした。

地域別では、北米が2023年に収益を上げる主要市場です。

結核検査市場-セグメンテーション分析：

世界の結核検査市場は、検査タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場は検査タイプ別では7つのカテゴリーに分類される：X線撮影法、検査室診断法、分子診断法、潜伏感染検出、サイトカイン検出アッセイ、薬剤耐性検出（DST）、ファージアッセイ、その他の検査タイプ。結核検査市場では、分子診断法、特にPCR（ポリメラーゼ連鎖反応）法が最も支配的な分野です。PCR法は、少量の菌でも結核菌を検出できる速さと正確さで高く評価されています。この方法によって迅速な診断が可能となり、タイムリーな治療を開始し、病気の蔓延を抑制するために極めて重要です。また、薬剤耐性を同定する能力も治療の選択肢を広げます。その結果、PCRは結核診断を進歩させ、患者の転帰を改善する上で重要な役割を果たしています。

市場はエンドユーザー別でカテゴリー分けされている：病理検査室、POCT、その他です。結核検査市場では、病理検査室が最も重要なセグメントです。これらの検査室は培養法や分子診断法を含む様々な検査を実施するために不可欠です。病理検査室は多くの検体を扱い、結核の診断と管理に不可欠な正確な結果を提供することができます。専門的な機器と訓練を受けたスタッフにより、複雑な検査も正確に行われます。結核が大きな健康問題であり続ける中、病理検査室の役割は極めて重要であり、市場の主要セグメントとなっています。

結核検査市場-地理的洞察

北米の結核検査市場は高度な診断技術に焦点を当てています。米国とカナダがこの地域のリーダーであり、ヘルスケアと調査に多額の投資を行っています。米国では、疾病対策予防センター（CDC）が結核検査と予防を推進し、結核に対する認識を高めています。症例の迅速な特定に役立つ分子診断のような迅速検査法のニーズが高まっています。政府のプログラムや資金援助も、特にハイリスクグループを対象とした検査を支援しています。市場の主要企業は技術革新を推進し、検査をより身近なものにしています。全体として、北米は結核検査と治療努力の向上において重要な役割を果たしています。

結核検査市場-競合情勢：

結核検査市場は、複数の主要企業による競合情勢が特徴です。サーモフィッシャーサイエンティフィックやロシュのような企業は、先進的な診断ツールの提供でリードしています。Abbott LaboratoriesとBDは、結核を効果的に検出するためのさまざまな検査を提供しています。Cepheid社は迅速分子検査ソリューションで知られ、その人気はますます高まっています。

HologicとQIAGENも検査精度を向上させる革新的な技術で貢献しています。その他の主要企業には、特殊な検査法に特化したBioMerieux社やOxford Immunotec社があります。このように多様な製品を提供することで、効率的な結核診断に対する世界の需要の高まりに応えています。

目次

第1章 結核検査市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 結核検査の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 結核検査産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 結核検査市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 結核検査市場情勢

  • 結核検査市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 結核検査市場- 検査タイプ別

  • 概要
    • 検査タイプ別セグメントシェア分析
    • 放射線学的方法
    • 診断検査法
      • 顕微鏡検査
      • 培養技術的検査
      • 血清学的検査
    • 分子診断
      • ポリメラーゼ連鎖反応（PCR）
      • 核酸増幅検査（NAAT）
      • GeneXpert MTB/RIF
    • 潜在感染の検出
      • ツベルクリン皮膚テスト（TST）
      • インターフェロンガンマ放出アッセイ（IGRA）
    • サイトカイン検出アッセイ
    • 薬剤耐性の検出（DST）
    • ファージアッセイ
    • その他

第8章 結核検査市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病理学研究室
    • ポイントオブケア検査（POCT）
    • その他

第9章 結核検査市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 結核検査業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific
    • Roche
    • Abbott Laboratories
    • BD（Becton, Dickinson and Company）
    • Hologic
    • Cepheid
    • QIAGEN
    • Molecular Testing Labs
    • Siemens Healthineers
    • Genomictree
    • BioMerieux
    • Oxford Immunotec
    • F. Hoffmann-La Roche AG
    • Eiken Chemical Co., Ltd.
    • Hain Lifescience GmbH

第11章 アナリストの全方位展望

目次
Product Code: ANV3933

REPORT HIGHLIGHT

Tuberculosis Testing Market size was valued at USD 2,290.32 million in 2023, expanding at a CAGR of 5.99% from 2024 to 2032.

The tuberculosis (TB) testing market refers to the industry that provides various tests to diagnose TB, a serious infectious disease that mainly affects the lungs. This market includes different types of tests, such as skin tests, blood tests, and imaging tests like X-rays. The demand for TB testing has increased due to the rising number of TB cases worldwide and the need for early detection and treatment. Many organizations, including governments and health agencies, invest in TB testing to control the disease. Overall, the TB testing market plays a crucial role in public health by helping to identify and treat those affected by the disease.

Tuberculosis Testing Market- Market Dynamics

The increasing prevalence of drug-resistant tuberculosis strains drives testing demand.

The increasing prevalence of drug-resistant tuberculosis (TB) strains is a significant driver for the tuberculosis testing market. As these resistant strains become more common, timely and accurate testing is essential for effective treatment. According to the Centers for Disease Control and Prevention (CDC), about 3% of newly diagnosed TB cases in the U.S. are drug-resistant. This statistic highlights the urgent need for advanced testing solutions to identify and manage resistant strains effectively. Healthcare providers require reliable diagnostic tools to ensure appropriate treatment and control the spread of TB. As awareness grows, the demand for innovative testing methods will continue to rise, supporting market growth.

Tuberculosis Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.99% over the forecast period (2024-2032)

Based on Test Type segmentation, Molecular diagnostics was predicted to show maximum market share in the year 2023

Based on End-user segmentation, Pathological laboratories was the leading type in 2023

Based on Region, North America was the leading revenue generator in 2023

Tuberculosis Testing Market- Segmentation Analysis:

The Global Tuberculosis Testing Market is segmented based on Test Type, End User, and Region.

The market is divided into Seven categories based on Test Type: Radiographic method, Diagnostic laboratory methods, Molecular diagnostics, Detection of latent infection, Cytokine detection assay, Detection of drug resistance (DST), Phage assay, and other test types. In the tuberculosis testing market, Molecular diagnostics, particularly the Polymerase Chain Reaction (PCR) method, is the most dominant segment. PCR is highly valued for its speed and accuracy in detecting Mycobacterium tuberculosis, even in small amounts of bacteria. This method allows for quick diagnosis, which is crucial for initiating timely treatment and controlling the spread of the disease. Its ability to identify drug resistance also enhances treatment options. As a result, PCR plays a key role in advancing tuberculosis diagnostics and improving patient outcomes.

The market is divided into categories based on End Users: Pathological laboratories, Point of care testing (POCT), and Others. In the tuberculosis testing market, pathological laboratories are the most important segment. These labs are essential for performing various tests, including culture methods and molecular diagnostics. They can handle many samples and provide accurate results, which is vital for diagnosing and managing TB. Their specialized equipment and trained staff ensure that complex tests are done correctly. As TB continues to be a major health issue, the role of pathological laboratories is crucial, making them the leading segment in the market.

Tuberculosis Testing Market- Geographical Insights

The North American tuberculosis testing market focuses on advanced diagnostic technologies. The United States and Canada are the leaders in this region, with significant investments in healthcare and research. In the U.S., the Centers for Disease Control and Prevention (CDC) promotes TB testing and prevention, raising awareness about the disease. There is a growing need for rapid testing methods, like molecular diagnostics, which help identify cases quickly. Government programs and funding also support testing, especially for high-risk groups. Major companies in the market drive innovation and make testing more accessible. Overall, North America plays an important role in improving tuberculosis testing and treatment efforts.

Tuberculosis Testing Market- Competitive Landscape:

The tuberculosis testing market features a competitive landscape with several key players. Companies like Thermo Fisher Scientific and Roche lead in providing advanced diagnostic tools. Abbott Laboratories and BD offer a range of tests that help detect TB effectively. Cepheid is known for its rapid molecular testing solutions, which are becoming increasingly popular.

Hologic and QIAGEN also contribute innovative technologies to improve testing accuracy. Other notable players include BioMerieux and Oxford Immunotec, focusing on specialized testing methods. This diversity in offerings helps meet the growing demand for efficient tuberculosis diagnostics worldwide.

Recent Developments:

In November 2023, BD and Bio Farma signed a memorandum of understanding (MOU) to work together on addressing tuberculosis. BD offered access to its advanced TB diagnostic tools, while the partnership improved the supply chain for TB solutions in Indonesia.

In February 2023, Fisher Scientific launched real-time PCR kits in India for detecting various infectious diseases. These kits cover a range of conditions, including genetic analysis (HLA B27), Multi-Drug-Resistant Tuberculosis (MTB MDR), Hepatitis B Virus (HBV), M. Tuberculosis complex (MTB), Human Immunodeficiency Virus (HIV), and Hepatitis C Virus (HCV).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TUBERCULOSIS TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Roche
  • Abbott Laboratories
  • BD (Becton, Dickinson, and Company)
  • Hologic
  • Cepheid
  • QIAGEN
  • Molecular Testing Labs
  • Siemens Healthineers
  • Genomictree
  • BioMerieux
  • Oxford Immunotec
  • F. Hoffmann-La Roche AG
  • Eiken Chemical Co., Ltd.
  • Hain Lifescience GmbH

GLOBAL TUBERCULOSIS TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Radiographic method
  • Diagnostic laboratory methods
  • Microscopy
  • Culture-based techniques
  • Serological tests
  • Molecular diagnostics
  • Polymerase chain reaction (PCR)
  • Nucleic acid amplification tests (NAAT)
  • GeneXpert MTB/RIF
  • Detection of latent infection
  • Tuberculin skin test (TST)
  • Interferon-gamma release assays (IGRAs)
  • Cytokine detection assay
  • Detection of drug resistance (DST)
  • Phage assay
  • Others

GLOBAL TUBERCULOSIS TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pathological laboratories
  • Point of care testing (POCT)
  • Others

GLOBAL TUBERCULOSIS TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Tuberculosis Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Tuberculosis Testing Market Snippet by Test Type
    • 2.1.2. Tuberculosis Testing Market Snippet by End User
    • 2.1.3. Tuberculosis Testing Market Snippet by Country
    • 2.1.4. Tuberculosis Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Tuberculosis Testing Key Market Trends

  • 3.1. Tuberculosis Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Tuberculosis Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Tuberculosis Testing Market Opportunities
  • 3.4. Tuberculosis Testing Market Future Trends

4. Tuberculosis Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tuberculosis Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tuberculosis Testing Market Landscape

  • 6.1. Tuberculosis Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Tuberculosis Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Radiographic method
    • 7.1.3. Diagnostic laboratory methods
      • 7.1.3.1. Microscopy
      • 7.1.3.2. Culture-based techniques
      • 7.1.3.3. Serological tests
    • 7.1.4. Molecular diagnostics
      • 7.1.4.1. Polymerase chain reaction (PCR)
      • 7.1.4.2. Nucleic acid amplification tests (NAAT)
      • 7.1.4.3. GeneXpert MTB/RIF
    • 7.1.5. Detection of latent infection
      • 7.1.5.1. Tuberculin skin test (TST)
      • 7.1.5.2. Interferon-gamma release assays (IGRAs)
    • 7.1.6. Cytokine detection assay
    • 7.1.7. Detection of drug resistance (DST)
    • 7.1.8. Phage assay
    • 7.1.9. Others

8. Tuberculosis Testing Market - By End User

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 8.1.2. Pathological laboratories
    • 8.1.3. Point of care testing (POCT)
    • 8.1.4. Others

9. Tuberculosis Testing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Tuberculosis Testing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Tuberculosis Testing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Tuberculosis Testing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Tuberculosis Testing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Tuberculosis Testing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Tuberculosis Testing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific
    • 10.2.2. Roche
    • 10.2.3. Abbott Laboratories
    • 10.2.4. BD (Becton, Dickinson and Company)
    • 10.2.5. Hologic
    • 10.2.6. Cepheid
    • 10.2.7. QIAGEN
    • 10.2.8. Molecular Testing Labs
    • 10.2.9. Siemens Healthineers
    • 10.2.10. Genomictree
    • 10.2.11. BioMerieux
    • 10.2.12. Oxford Immunotec
    • 10.2.13. F. Hoffmann-La Roche AG
    • 10.2.14. Eiken Chemical Co., Ltd.
    • 10.2.15. Hain Lifescience GmbH

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us